Global and USA Gastrointestinal Drugs Market Insights, Forecast to 2027

Global and USA Gastrointestinal Drugs Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Gastrointestinal Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Gastrointestinal Drugs Market Size Growth Rate by Type
1.2.2 Prescription Gastrointestinal Drug
1.2.3 OTC Gastrointestinal Drug
1.3 Market by Application
1.3.1 Global Gastrointestinal Drugs Market Size Growth Rate by Application
1.3.2 Chronic Gastritis
1.3.3 Functional Dyspepsia
1.3.4 Peptic Ulcer
1.3.5 Acute Gastroenteritis
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Gastrointestinal Drugs Market Size, Estimates and Forecasts
2.1.1 Global Gastrointestinal Drugs Revenue 2016-2027
2.1.2 Global Gastrointestinal Drugs Sales 2016-2027
2.2 Global Gastrointestinal Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Gastrointestinal Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Gastrointestinal Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Gastrointestinal Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Gastrointestinal Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Gastrointestinal Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Gastrointestinal Drugs Revenue Forecast by Region (2022-2027)
3 Global Gastrointestinal Drugs Competitor Landscape by Players
3.1 Global Top Gastrointestinal Drugs Manufacturers by Sales
3.1.1 Global Gastrointestinal Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Gastrointestinal Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Gastrointestinal Drugs Manufacturers by Revenue
3.2.1 Key Gastrointestinal Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Gastrointestinal Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Gastrointestinal Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Gastrointestinal Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Gastrointestinal Drugs Revenue in 2020
3.2.6 Global Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Gastrointestinal Drugs Price by Manufacturers
3.4 Global Gastrointestinal Drugs Manufacturing Base Distribution, Product Types
3.4.1 Gastrointestinal Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gastrointestinal Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Gastrointestinal Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Gastrointestinal Drugs Market Size by Type (2016-2021)
4.1.1 Global Gastrointestinal Drugs Sales by Type (2016-2021)
4.1.2 Global Gastrointestinal Drugs Revenue by Type (2016-2021)
4.1.3 Gastrointestinal Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Gastrointestinal Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Gastrointestinal Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Gastrointestinal Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Gastrointestinal Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Gastrointestinal Drugs Market Size by Application (2016-2021)
5.1.1 Global Gastrointestinal Drugs Sales by Application (2016-2021)
5.1.2 Global Gastrointestinal Drugs Revenue by Application (2016-2021)
5.1.3 Gastrointestinal Drugs Price by Application (2016-2021)
5.2 Gastrointestinal Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Gastrointestinal Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Gastrointestinal Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Gastrointestinal Drugs Price Forecast by Application (2022-2027)
6 USA by Players, Type and Application
6.1 USA Gastrointestinal Drugs Market Size YoY Growth 2016-2027
6.1.1 USA Gastrointestinal Drugs Sales YoY Growth 2016-2027
6.1.2 USA Gastrointestinal Drugs Revenue YoY Growth 2016-2027
6.1.3 USA Gastrointestinal Drugs Market Share in Global Market 2016-2027
6.2 USA Gastrointestinal Drugs Market Size by Players (International and Local Players)
6.2.1 USA Top Gastrointestinal Drugs Players by Sales (2016-2021)
6.2.2 USA Top Gastrointestinal Drugs Players by Revenue (2016-2021)
6.3 USA Gastrointestinal Drugs Historic Market Review by Type (2016-2021)
6.3.1 USA Gastrointestinal Drugs Sales Market Share by Type (2016-2021)
6.3.2 USA Gastrointestinal Drugs Revenue Market Share by Type (2016-2021)
6.3.3 USA Gastrointestinal Drugs Price by Type (2016-2021)
6.4 USA Gastrointestinal Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 USA Gastrointestinal Drugs Sales Forecast by Type (2022-2027)
6.4.2 USA Gastrointestinal Drugs Revenue Forecast by Type (2022-2027)
6.4.3 USA Gastrointestinal Drugs Price Forecast by Type (2022-2027)
6.5 USA Gastrointestinal Drugs Historic Market Review by Application (2016-2021)
6.5.1 USA Gastrointestinal Drugs Sales Market Share by Application (2016-2021)
6.5.2 USA Gastrointestinal Drugs Revenue Market Share by Application (2016-2021)
6.5.3 USA Gastrointestinal Drugs Price by Application (2016-2021)
6.6 USA Gastrointestinal Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 USA Gastrointestinal Drugs Sales Forecast by Application (2022-2027)
6.6.2 USA Gastrointestinal Drugs Revenue Forecast by Application (2022-2027)
6.6.3 USA Gastrointestinal Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Gastrointestinal Drugs Market Size YoY Growth 2016-2027
7.2 North America Gastrointestinal Drugs Market Facts & Figures by Country
7.2.1 North America Gastrointestinal Drugs Sales by Country (2016-2021)
7.2.2 North America Gastrointestinal Drugs Revenue by Country (2016-2021)
7.2.3 the United States
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Gastrointestinal Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Gastrointestinal Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Gastrointestinal Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Gastrointestinal Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Gastrointestinal Drugs Market Size YoY Growth 2016-2027
9.2 Europe Gastrointestinal Drugs Market Facts & Figures by Country
9.2.1 Europe Gastrointestinal Drugs Sales by Country (2016-2021)
9.2.2 Europe Gastrointestinal Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 UK
9.2.6 Italy
10 Latin America
10.1 Latin America Gastrointestinal Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Gastrointestinal Drugs Market Facts & Figures by Country
10.2.1 Latin America Gastrointestinal Drugs Sales by Country (2016-2021)
10.2.2 Latin America Gastrointestinal Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Gastrointestinal Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Gastrointestinal Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Gastrointestinal Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Gastrointestinal Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Corporation Information
12.1.2 AstraZeneca Description and Business Overview
12.1.3 AstraZeneca Gastrointestinal Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AstraZeneca Gastrointestinal Drugs Products Offered
12.1.5 AstraZeneca Recent Development
12.2 Sanofi
12.2.1 Sanofi Corporation Information
12.2.2 Sanofi Description and Business Overview
12.2.3 Sanofi Gastrointestinal Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sanofi Gastrointestinal Drugs Products Offered
12.2.5 Sanofi Recent Development
12.3 Bayer
12.3.1 Bayer Corporation Information
12.3.2 Bayer Description and Business Overview
12.3.3 Bayer Gastrointestinal Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Bayer Gastrointestinal Drugs Products Offered
12.3.5 Bayer Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Description and Business Overview
12.4.3 Pfizer Gastrointestinal Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Pfizer Gastrointestinal Drugs Products Offered
12.4.5 Pfizer Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Corporation Information
12.5.2 GlaxoSmithKline Description and Business Overview
12.5.3 GlaxoSmithKline Gastrointestinal Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 GlaxoSmithKline Gastrointestinal Drugs Products Offered
12.5.5 GlaxoSmithKline Recent Development
12.6 Teva
12.6.1 Teva Corporation Information
12.6.2 Teva Description and Business Overview
12.6.3 Teva Gastrointestinal Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Teva Gastrointestinal Drugs Products Offered
12.6.5 Teva Recent Development
12.7 Zeria (Tillotts)
12.7.1 Zeria (Tillotts) Corporation Information
12.7.2 Zeria (Tillotts) Description and Business Overview
12.7.3 Zeria (Tillotts) Gastrointestinal Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Zeria (Tillotts) Gastrointestinal Drugs Products Offered
12.7.5 Zeria (Tillotts) Recent Development
12.8 Perrigo
12.8.1 Perrigo Corporation Information
12.8.2 Perrigo Description and Business Overview
12.8.3 Perrigo Gastrointestinal Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Perrigo Gastrointestinal Drugs Products Offered
12.8.5 Perrigo Recent Development
12.9 Boehringer Ingelheim
12.9.1 Boehringer Ingelheim Corporation Information
12.9.2 Boehringer Ingelheim Description and Business Overview
12.9.3 Boehringer Ingelheim Gastrointestinal Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Boehringer Ingelheim Gastrointestinal Drugs Products Offered
12.9.5 Boehringer Ingelheim Recent Development
12.10 Purdue Pharma
12.10.1 Purdue Pharma Corporation Information
12.10.2 Purdue Pharma Description and Business Overview
12.10.3 Purdue Pharma Gastrointestinal Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Purdue Pharma Gastrointestinal Drugs Products Offered
12.10.5 Purdue Pharma Recent Development
12.11 AstraZeneca
12.11.1 AstraZeneca Corporation Information
12.11.2 AstraZeneca Description and Business Overview
12.11.3 AstraZeneca Gastrointestinal Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 AstraZeneca Gastrointestinal Drugs Products Offered
12.11.5 AstraZeneca Recent Development
12.12 Abbott
12.12.1 Abbott Corporation Information
12.12.2 Abbott Description and Business Overview
12.12.3 Abbott Gastrointestinal Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Abbott Products Offered
12.12.5 Abbott Recent Development
12.13 Jiangzhong
12.13.1 Jiangzhong Corporation Information
12.13.2 Jiangzhong Description and Business Overview
12.13.3 Jiangzhong Gastrointestinal Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Jiangzhong Products Offered
12.13.5 Jiangzhong Recent Development
12.14 Xian-Janssen
12.14.1 Xian-Janssen Corporation Information
12.14.2 Xian-Janssen Description and Business Overview
12.14.3 Xian-Janssen Gastrointestinal Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Xian-Janssen Products Offered
12.14.5 Xian-Janssen Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Gastrointestinal Drugs Industry Trends
13.2 Gastrointestinal Drugs Market Drivers
13.3 Gastrointestinal Drugs Market Challenges
13.4 Gastrointestinal Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Gastrointestinal Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Gastrointestinal Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Prescription Gastrointestinal Drug
Table 3. Major Manufacturers of OTC Gastrointestinal Drug
Table 4. Global Gastrointestinal Drugs Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 5. Global Gastrointestinal Drugs Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Gastrointestinal Drugs Sales by Regions (2016-2021) & (K Units)
Table 7. Global Gastrointestinal Drugs Sales Market Share by Regions (2016-2021)
Table 8. Global Gastrointestinal Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Gastrointestinal Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 10. Global Gastrointestinal Drugs Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Gastrointestinal Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Gastrointestinal Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Gastrointestinal Drugs Sales by Manufacturers (2016-2021) (K Units)
Table 14. Global Gastrointestinal Drugs Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Gastrointestinal Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 16. Gastrointestinal Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Gastrointestinal Drugs Revenue Share by Manufacturers (2016-2021)
Table 18. Global Gastrointestinal Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Gastrointestinal Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Drugs as of 2020)
Table 20. Key Manufacturers Gastrointestinal Drugs Price (2016-2021) (USD/Unit)
Table 21. Gastrointestinal Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Gastrointestinal Drugs Product Type
Table 23. Date of International Manufacturers Enter into Gastrointestinal Drugs Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Gastrointestinal Drugs Sales by Type (2016-2021) (K Units)
Table 26. Global Gastrointestinal Drugs Sales Share by Type (2016-2021)
Table 27. Global Gastrointestinal Drugs Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Gastrointestinal Drugs Revenue Share by Type (2016-2021)
Table 29. Gastrointestinal Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 30. Global Gastrointestinal Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 31. Global Gastrointestinal Drugs Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Gastrointestinal Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Gastrointestinal Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Gastrointestinal Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 35. Global Gastrointestinal Drugs Sales by Application (2016-2021) (K Units)
Table 36. Global Gastrointestinal Drugs Sales Share by Application (2016-2021)
Table 37. Global Gastrointestinal Drugs Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Gastrointestinal Drugs Revenue Share by Application (2016-2021)
Table 39. Gastrointestinal Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 40. Global Gastrointestinal Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 41. Global Gastrointestinal Drugs Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Gastrointestinal Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Gastrointestinal Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Gastrointestinal Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 45. USA Gastrointestinal Drugs Sales (K Units) of Key Companies (2016-2021)
Table 46. USA Gastrointestinal Drugs Sales Share by Company (2016-2021)
Table 47. USA Gastrointestinal Drugs Revenue (US$ Million) by Company (2016-2021)
Table 48. USA Gastrointestinal Drugs Revenue Share by Company (2016-2021)
Table 49. USA Gastrointestinal Drugs Sales (K Units) by Type (2016-2021)
Table 50. USA Gastrointestinal Drugs Sales Share by Type (2016-2021)
Table 51. USA Gastrointestinal Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. USA Gastrointestinal Drugs Price (USD/Unit) by Type (2016-2021)
Table 53. USA Gastrointestinal Drugs Sales (K Units) by Type (2022-2027)
Table 54. USA Gastrointestinal Drugs Sales Share by Type (2022-2027)
Table 55. USA Gastrointestinal Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. USA Gastrointestinal Drugs Revenue Share by Type (2022-2027)
Table 57. USA Gastrointestinal Drugs Price (USD/Unit) by Type (2022-2027)
Table 58. USA Gastrointestinal Drugs Sales (K Units) by Application (2016-2021)
Table 59. USA Gastrointestinal Drugs Sales Share by Application (2016-2021)
Table 60. USA Gastrointestinal Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. USA Gastrointestinal Drugs Price (USD/Unit) by Application (2016-2021)
Table 62. USA Gastrointestinal Drugs Sales (K Units) by Application (2022-2027)
Table 63. USA Gastrointestinal Drugs Sales Share by Application (2022-2027)
Table 64. USA Gastrointestinal Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. USA Gastrointestinal Drugs Revenue Share by Application (2022-2027)
Table 66. USA Gastrointestinal Drugs Price (USD/Unit) by Application (2022-2027)
Table 67. North America Gastrointestinal Drugs Sales by Country (2016-2021) & (K Units)
Table 68. North America Gastrointestinal Drugs Sales Market Share by Country (2016-2021)
Table 69. North America Gastrointestinal Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Gastrointestinal Drugs Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Gastrointestinal Drugs Sales by Region (2016-2021) & (K Units)
Table 72. Asia Pacific Gastrointestinal Drugs Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Gastrointestinal Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Gastrointestinal Drugs Revenue Market Share by Region (2016-2021)
Table 75. Europe Gastrointestinal Drugs Sales by Country (2016-2021) & (K Units)
Table 76. Europe Gastrointestinal Drugs Sales Market Share by Country (2016-2021)
Table 77. Europe Gastrointestinal Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Gastrointestinal Drugs Revenue Market Share by Country (2016-2021)
Table 79. Latin America Gastrointestinal Drugs Sales by Country (2016-2021) & (K Units)
Table 80. Latin America Gastrointestinal Drugs Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Gastrointestinal Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Gastrointestinal Drugs Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Gastrointestinal Drugs Sales by Country (2016-2021) & (K Units)
Table 84. Middle East and Africa Gastrointestinal Drugs Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Gastrointestinal Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Gastrointestinal Drugs Revenue Market Share by Country (2016-2021)
Table 87. AstraZeneca Corporation Information
Table 88. AstraZeneca Description and Business Overview
Table 89. AstraZeneca Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 90. AstraZeneca Gastrointestinal Drugs Product
Table 91. AstraZeneca Recent Development
Table 92. Sanofi Corporation Information
Table 93. Sanofi Description and Business Overview
Table 94. Sanofi Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 95. Sanofi Product
Table 96. Sanofi Recent Development
Table 97. Bayer Corporation Information
Table 98. Bayer Description and Business Overview
Table 99. Bayer Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 100. Bayer Product
Table 101. Bayer Recent Development
Table 102. Pfizer Corporation Information
Table 103. Pfizer Description and Business Overview
Table 104. Pfizer Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 105. Pfizer Product
Table 106. Pfizer Recent Development
Table 107. GlaxoSmithKline Corporation Information
Table 108. GlaxoSmithKline Description and Business Overview
Table 109. GlaxoSmithKline Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 110. GlaxoSmithKline Product
Table 111. GlaxoSmithKline Recent Development
Table 112. Teva Corporation Information
Table 113. Teva Description and Business Overview
Table 114. Teva Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 115. Teva Product
Table 116. Teva Recent Development
Table 117. Zeria (Tillotts) Corporation Information
Table 118. Zeria (Tillotts) Description and Business Overview
Table 119. Zeria (Tillotts) Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 120. Zeria (Tillotts) Product
Table 121. Zeria (Tillotts) Recent Development
Table 122. Perrigo Corporation Information
Table 123. Perrigo Description and Business Overview
Table 124. Perrigo Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 125. Perrigo Product
Table 126. Perrigo Recent Development
Table 127. Boehringer Ingelheim Corporation Information
Table 128. Boehringer Ingelheim Description and Business Overview
Table 129. Boehringer Ingelheim Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 130. Boehringer Ingelheim Product
Table 131. Boehringer Ingelheim Recent Development
Table 132. Purdue Pharma Corporation Information
Table 133. Purdue Pharma Description and Business Overview
Table 134. Purdue Pharma Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 135. Purdue Pharma Product
Table 136. Purdue Pharma Recent Development
Table 137. C.B. Fleet Corporation Information
Table 138. C.B. Fleet Description and Business Overview
Table 139. C.B. Fleet Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 140. C.B. Fleet Product
Table 141. C.B. Fleet Recent Development
Table 142. Abbott Corporation Information
Table 143. Abbott Description and Business Overview
Table 144. Abbott Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 145. Abbott Product
Table 146. Abbott Recent Development
Table 147. Jiangzhong Corporation Information
Table 148. Jiangzhong Description and Business Overview
Table 149. Jiangzhong Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 150. Jiangzhong Product
Table 151. Jiangzhong Recent Development
Table 152. Xian-Janssen Corporation Information
Table 153. Xian-Janssen Description and Business Overview
Table 154. Xian-Janssen Gastrointestinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 155. Xian-Janssen Product
Table 156. Xian-Janssen Recent Development
Table 157. Gastrointestinal Drugs Market Trends
Table 158. Gastrointestinal Drugs Market Drivers
Table 159. Gastrointestinal Drugs Market Challenges
Table 160. Gastrointestinal Drugs Market Restraints
Table 161. Gastrointestinal Drugs Customers List
Table 162. Gastrointestinal Drugs Distributors List
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Gastrointestinal Drugs Product Picture
Figure 2. Global Gastrointestinal Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Prescription Gastrointestinal Drug Product Picture
Figure 4. OTC Gastrointestinal Drug Product Picture
Figure 5. Global Gastrointestinal Drugs Sales Market Share by Application in 2020 & 2027
Figure 6. Chronic Gastritis
Figure 7. Functional Dyspepsia
Figure 8. Peptic Ulcer
Figure 9. Acute Gastroenteritis
Figure 10. Other
Figure 11. Gastrointestinal Drugs Report Years Considered
Figure 12. Global Gastrointestinal Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Gastrointestinal Drugs Market Size 2016-2027 (US$ Million)
Figure 14. Global Gastrointestinal Drugs Sales 2016-2027 (K Units)
Figure 15. Global Gastrointestinal Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Gastrointestinal Drugs Sales Market Share by Region (2016-2021)
Figure 17. Global Gastrointestinal Drugs Sales Market Share by Region in 2020
Figure 18. Global Gastrointestinal Drugs Revenue Market Share by Region (2016-2021)
Figure 19. Global Gastrointestinal Drugs Revenue Market Share by Region in 2020
Figure 20. Global Gastrointestinal Drugs Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Gastrointestinal Drugs Revenue in 2020
Figure 22. Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Gastrointestinal Drugs Sales Market Share by Type (2016-2021)
Figure 24. Global Gastrointestinal Drugs Sales Market Share by Type in 2020
Figure 25. Global Gastrointestinal Drugs Revenue Market Share by Type (2016-2021)
Figure 26. Global Gastrointestinal Drugs Revenue Market Share by Type in 2020
Figure 27. Global Gastrointestinal Drugs Sales Market Share by Application (2016-2021)
Figure 28. Global Gastrointestinal Drugs Sales Market Share by Application in 2020
Figure 29. Global Gastrointestinal Drugs Revenue Market Share by Application (2016-2021)
Figure 30. Global Gastrointestinal Drugs Revenue Market Share by Application in 2020
Figure 31. USA Gastrointestinal Drugs Sales Growth Rate 2016-2027 (K Units)
Figure 32. USA Gastrointestinal Drugs Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. USA Gastrointestinal Drugs Market Share in Global Market 2016-2027
Figure 34. USA 5 and 10 Largest Gastrointestinal Drugs Players Market Share by Revenue in Gastrointestinal Drugs in 2020
Figure 35. USA Gastrointestinal Drugs Revenue Share by Type (2016-2021)
Figure 36. USA Gastrointestinal Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 37. USA Gastrointestinal Drugs Revenue Share by Application (2016-2021)
Figure 38. USA Gastrointestinal Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Gastrointestinal Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 40. North America Gastrointestinal Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Gastrointestinal Drugs Sales Market Share by Country in 2020
Figure 42. North America Gastrointestinal Drugs Revenue Market Share by Country in 2020
Figure 43. the United States Gastrointestinal Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 44. the United States Gastrointestinal Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Gastrointestinal Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 46. Canada Gastrointestinal Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe Gastrointestinal Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 48. Europe Gastrointestinal Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe Gastrointestinal Drugs Sales Market Share by Country in 2020
Figure 50. Europe Gastrointestinal Drugs Revenue Market Share by Country in 2020
Figure 51. Germany Gastrointestinal Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 52. Germany Gastrointestinal Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France Gastrointestinal Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 54. France Gastrointestinal Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. UK Gastrointestinal Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 56. UK Gastrointestinal Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy Gastrointestinal Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 58. Italy Gastrointestinal Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia Gastrointestinal Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 60. Russia Gastrointestinal Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Asia Pacific Gastrointestinal Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 62. Asia Pacific Gastrointestinal Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 63. Asia Pacific Gastrointestinal Drugs Sales Market Share by Region in 2020
Figure 64. Asia Pacific Gastrointestinal Drugs Revenue Market Share by Region in 2020
Figure 65. China Gastrointestinal Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 66. China Gastrointestinal Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. Japan Gastrointestinal Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 68. Japan Gastrointestinal Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. South Korea Gastrointestinal Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 70. South Korea Gastrointestinal Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. India Gastrointestinal Drugs Sales Growth Rate (

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110

According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period. The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......

Global Lansoprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 102

The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......

Global Esomeprazole Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 89

The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......

Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 126

Market Overview of Global Irritable Bowel Syndrome (IBS) market: According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......

Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 109

Market Overview of Global Diarrhea Drug market: According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......

Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 96

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......

Global Lansoprazole Professional Survey Report 2023, Forecast to 2028

Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 136

Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......

Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 113

Market Overview of Global Pentasa (Ulcerative Colitis) market: According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs